Table 2 Baseline characteristics between Rad_score-high and Rad_score-low groups
From: CT radiomics prediction of CXCL9 expression and survival in ovarian cancer
Variables | Total (n = 57) | Low (n = 11) | High (n = 46) | p |
|---|---|---|---|---|
Age, n (%) | Â | Â | Â | 0.948 |
  ~ 59 | 28 (49.1) | 6 (54.5) | 22 (47.8) |  |
 60 ~  | 29 (50.9) | 5 (45.5) | 24 (52.2) |  |
Chemotherapy, n (%) | Â | Â | Â | 1 |
 YES | 57 (100) | 11 (100) | 46 (100) |  |
Venous_invasion, n (%) | Â | Â | Â | 0.87 |
 NO | 5 (8.8) | 1 (9.1) | 4 (8.7) |  |
 Unknown | 39 (68.4) | 7 (63.6) | 32 (69.6) |  |
 YES | 13 (22.8) | 3 (27.3) | 10 (21.7) |  |
Lymphatic_invasion, n (%) | Â | Â | Â | 0.682 |
 NO | 5 (8.8) | 1 (9.1) | 4 (8.7) |  |
 Unknown | 33 (57.9) | 5 (45.5) | 28 (60.9) |  |
 YES | 19 (33.3) | 5 (45.5) | 14 (30.4) |  |
Tumor_residual_disease, n (%) | Â | Â | Â | 0.635 |
 1–10 mm | 31 (54.4) | 8 (72.7) | 23 (50) |  |
 10 mm ~  | 12 (21.1) | 1 (9.1) | 11 (23.9) |  |
 No Macroscopic disease | 9 (15.8) | 1 (9.1) | 8 (17.4) |  |
 Unknown | 5 (8.8) | 1 (9.1) | 4 (8.7) |  |
Histologic_grade, n (%) | Â | Â | Â | 1 |
 G1/G2 | 5 (8.8) | 1 (9.1) | 4 (8.7) |  |
 G3/G4/GX | 52 (91.2) | 10 (90.9) | 42 (91.3) |  |
FIGO_stage, n (%) | Â | Â | Â | 0.244 |
 I/II | 5 (8.8) | 2 (18.2) | 3 (6.5) |  |
 III/IV | 52 (91.2) | 9 (81.8) | 43 (93.5) |  |
OS, n (%) | Â | Â | Â | 0.201 |
 Alive | 28 (49.1) | 3 (27.3) | 25 (54.3) |  |
 Dead | 29 (50.9) | 8 (72.7) | 21 (45.7) |  |
 OS.time, Mean ± SD | 42.9 ± 28.59 | 40.42 ± 21.11 | 43.49 ± 30.28 | 0.697 |